|
KMID : 0359920060250050717
|
|
Korean Journal of Nephrology
2006 Volume.25 No. 5 p.717 ~ p.725
|
|
|
The Role of Angiotensin 2 and Endothelin-1 on the Growth of Arterial and Venous Smooth Muscle Cells
|
|
Kim Seung-Jung
|
|
|
Abstract
|
|
|
Background : Hemodialysis vascular access stenosis is caused by the proliferation of vascular smooth muscle cells (SMC), and the stenotic lesions occur primarily at the graft-vein anastomosis or venous site. Angiotensin II (Ang II) and endothelin- 1 (ET-1) have been implicated in the proliferation of SMC, but the relative responsiveness of arterial and venous SMC to Ang II or ET-1 is unknown.
Methods : Human aortic and venous SMC were cultured in a ATCC medium containing 10% serum. Ang II (1-1000 nmol/L), ET-1 (0.1-1 μmol/L), captopril (1-10 μmol/L), losartan (1-10 μmol/L), BQ123 (1 μmol/L) or BQ788 (1 μmol/L) were added. After 72 hours, we subjected the cell to a mitochondrial enzymatic (methylthiazoletetrazolium, MTT) assay in order to assess the cell proliferation. We used RTPCR to observe Ang II or ET-1 receptors.
Results : Ang II increased the proliferation of aortic SMC in a dose-dependent manner, and losartan (not captopril) inhibited the effects of Ang II. However, Ang II failed in increasing the proliferation of venous SMC. Contrary to our expectation, it was ET-1 that increased the proliferation of venous SMC, although it failed to increase the proliferation of aortic SMC. Both BQ123 and BQ788 inhibited the effects of ET-1 in venous SMC. Both aortic and venous SMC had receptors for Ang II and ET-1.
Conclusion : This study suggests that strategies for the prevention of vascular access stenosis should take into account the fact that lesions at venous sites may respond differently to various anti-proliferative drugs than do those at arterial sites. (Korean J Nephrol 2006;25(5):717-725)
|
|
|
KEYWORD
|
|
|
Angiotensin 2, Endothelin-1, Arterial and venous smooth muscle cells, Vascular access stenosis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|